Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
Formula attenuates 99% of 365 coronaviruses in computer models
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Subscribe To Our Newsletter & Stay Updated
